Diagnostic Testing of Primary Vitreo-Retinal Lymphoma


  • A. Bajwa Massachusetts Eye Research and Surgery Institutionand Ocular Immunology and Uveitis Foundation, Cambridge, MA, USA
  • C. Stephen Foster Massachusetts Eye Research and Surgery Institutionand Ocular Immunology and Uveitis Foundation, Cambridge, MA, USA and Harvard Medical School, Cambridge, MA, USA




Primary vitreoretinal lymphoma, intraocular lymphoma, diagnosis, CNS lymphoma.


 Primary Vitreo-Retinal Lymphoma (PVRL) or Primary Intra-Ocular Lymphoma (PIOL) is a rare malignancy often seen as a context of primary central nervous system lymphoma (PCNSL). This article reviews the diagnostic approach of PVRL.

The techniques for diagnosing PVRL from ocular biopsy specimens includes cytologic analysis, immuno-cytochemistry, flow-cytometry, polymerase chain reaction (PCR) to detect V-J Ig gene re-arrangements, and analysis of IL6, IL10 in aqueous or vitreous fluid.

Currently, cytology in combination with immunohistochemistry is considered the gold standard for the diagnosis of PVRL. But ancillary tests including IgH, TCR gene rearrangements and cytokine analysis are reliable biomarkers for B and T cell PVRL. Genetic testing with t(14:18) detection may show promising results in future.


Bishop JE, Salmonsen PC. Presumed intraocular Hodgkin’s disease. Ophthalmology 1985; 17: 589-92.

Givner I. Malignant lymphoma with ocular involvement: A clinicopathological report. Am J Ophthalmol 1955; 39: 29-32.

Barr CC, Green WR, Payne JW, et al. Intraocular reticulum cell sarcoma: Clinicopathologic study of four cases and review of the literature. Surv Ophthalmol 1975; 19: 224-39.

Lijung B, Char D, Miller D, et al. Intraocular lymphoma: Cytologic diagnosis and role of immunologic markers. Acta Cytologica 1988; 32: 840-7.

National Cancer Institute. [accessed May 8, 2011] Surveillance, Epidemiology, and End Results. Fast Stats: Statistics Stratified by Cancer Site.

Chan CC, Buggage RR, Nussenblatt RB. Intraocular lymphoma. Curr Opin Ophthalmol 2002; 13: 411-18. http://dx.doi.org/10.1097/00055735-200212000-00012

Burnier MN, Stockl FA, Dolmetsch AM. Large B-cell lymphoma of the retina and CNS. Presented at the 1994 Annual Meeting of the Eastern Ophthalmic Pathology Society, Boston, Mass. October 1994.

Babu K, Murthy KR, Krishnakumar S. Two successive ocular malignancies in the same eye of a HIV-positive patient: a case report. Ocul Immunol Inflamm 2010; 18: 101-103. http://dx.doi.org/10.3109/09273940903374237

Harbour JW, Char DH. Intraocular lymphoid tumors. In: Chang S, Shields J, Green WR, Eds. Retina, Vitreous, Macular: A Comprehensive Text. Philadelphia: Saunders. 1998; pp. 1204-1216.

Mathai A, Lall A, Jain R, Pathengay A. Systemic non-Hodgkin’s lymphoma masquerading as Vogt-Koyanagi-Harada disease in an HIV-positive patient. Clin Experiment Ophthalmol 2006; 34: 280-82. http://dx.doi.org/10.1111/j.1442-9071.2006.01205.x

Coupland SE, Heimann H, Bechrakis NE. Primary intraocular lymphoma: A review of the clinical, histopathological and molecular biological features. Graefes Arch Clin Exp Ophthalmol 2004; 242: 901-13. http://dx.doi.org/10.1007/s00417-004-0973-0

Hochberg FH, Miller DC. Primary central nervous system lymphoma. J Neurosurg 1988; 68: 835-53. http://dx.doi.org/10.3171/jns.1988.68.6.0835

DeAngelis LM, Yahalom J, Heinemann MH, et al. Primary CNS lymphoma: Combined treatment with chemotherapy and radiotherapy. Neurology 1990; 40: 80-86. http://dx.doi.org/10.1212/WNL.40.1.80

Hong JT, Chae JB, Lee JY, et al. Ocular involvement in patients with primary CNS lymphoma. J Neurooncol 2011; 102: 139-45. http://dx.doi.org/10.1007/s11060-010-0303-9

Freeman LN, Schachat AP, Knox DL, Michels RG, Green WR. Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma. Ophthalmology 1987; 94: 1631-39.

Berenbom A, Davila RM, Lin HS, Harbour JW. Treatment outcomes for primary intraocular lymphoma: implications for external beam radiotherapy. Eye 2007; 21: 1198-201. http://dx.doi.org/10.1038/sj.eye.6702437

Hoffman PM, McKelvie P, Hall AJ, Stawell RJ, Santamaria JD. Intraocular lymphoma: a series of 14 patients with clinicopathological features and treatment outcomes. Eye 2003; 17: 513-21. http://dx.doi.org/10.1038/sj.eye.6700378

Corriveau C, Easterbrook M, Payne D. Lymphoma simulating uveitis (masquerade syndrome). Can J Ophthalmol 1986; 21: 144-9.

Mochizuki M, Singh AD. Epidemiology and clinical features of intraocular lymphoma. Ocul Immunol Inflamm 2009; 17: 69-72. http://dx.doi.org/10.1080/09273940902957305

Davis JL. Diagnosis of intraocular lymphoma. Ocul Immunol Inflamm 2004; 12: 7-16. http://dx.doi.org/10.1076/ocii.

Turaka K, Bryan JS, et al. Vtreoretinal Lymphoma: Changing trends in diagnosis and local treatment modalities at a single institution. Clinical Lymphoma, Myeloma & Leukemia, (in press, accepted: July 26, 2012).

Fardeau C, Lee CP, Merle-Béral H, et al. Retinal fluorescein, indocyanine green angiography, and optic coherence tomography in non-Hodgkin’s primary intraocular lymphoma. Am J Ophthalmol 2009; 147: 886-894. 894.e881.

Peterson K, Gordon KB, Heinemann MH, et al. The clinical spectrum of ocular lymphoma. Cancer 1993; 72: 843-9. http://dx.doi.org/10.1002/1097-0142(19930801)72:3<843::AID-CNCR2820720333>3.0.CO;2-#

Raparia K, Chang CC, Chévez-Barrios P. Intraocular lymphoma: diagnostic approach and immunophenotypic findings in vitrectomy specimens. Arch Pathol Lab Med 2009; 133: 1233-7.

Sen HN, Bodaghi B, Hoang PL, et al. Primary intraocular lymphoma: diagnosis and differential diagnosis. Ocul Immunol Inflamm 2009; 17: 133-41. http://dx.doi.org/10.1080/09273940903108544

Rajagopal R, Harbour JW. Diagnostic testing and treatment choices in primary vitreoretinal lymphoma. Retina 2011; 31: 435-40. http://dx.doi.org/10.1097/IAE.0b013e31820a6743

Ishida T, Ohno-Matsui K, Kaneko Y, et al. Fundus autofluorescence patterns in eyes with primary intraocular lymphoma. Retina 2010; 30: 23-32. http://dx.doi.org/10.1097/IAE.0b013e3181b408a2

Chan CC, Rubenstein JL, Coupland SE, et al. Primary vitreoretinal lymphoma: a report from an international primary Central Nervous System Lymphoma Collaborative Group symposium. Oncologist 2011; 16: 1589-99. http://dx.doi.org/10.1634/theoncologist.2011-0210

Forooghian F, Merkur AB, et al. High-definition optical coherence tomography features of primary vitreoretinal lymphoma. Ophthalmic Surg Lasers Imaging 2011 September 29; 42. Online: e97-e99.

Yeh S, Wilson DJ. Combination intravitreal rituximab and methotrexate for massive suretinal lymphoma. Eye (Lond) 2010; 24: 1625-27. http://dx.doi.org/10.1038/eye.2010.111

Freilich RJ, DeAngelis LM. Primary central nervous system lymphoma. Neurol Clin 1995; 13: 901-14.

DeAngelis LM. Primary central nervous system lymphoma. Curr Opin Neurol 1999; 12: 687-91. http://dx.doi.org/10.1097/00019052-199912000-00005

Qualman SJ, Mendelsohn G, Mann RB, et al. Intraocular lymphomas: Natural history based on a clinicopathologic study of eight cases and review of the literature. Cancer 1983; 52: 878-86. http://dx.doi.org/10.1002/1097-0142(19830901)52:5<878::AID-CNCR2820520523>3.0.CO;2-D

Wang Y, Shen D, Wang VM, et al. Molecular biomarkers for the diagnosis of primary vitreoretinal lymphoma. Int J Mol Sci 2011; 12: 5684-97. http://dx.doi.org/10.3390/ijms12095684

Davis JL. Diagnosis of intraocular lymphoma. Ocul Immunol Inflamm 2004; 12: 7-16. http://dx.doi.org/10.1076/ocii.

Akpek EK, Ahmed I, Hochberg FH, et al. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes. Ophthalmology 1999; 106: 1805-10. http://dx.doi.org/10.1016/S0161-6420(99)90341-X

Farkas T, Harbour JW, Davila RM. Cytologic diagnosis of intraocular lymphoma in vitreous aspirates. Acta Cytol 2004; 48: 487-91. http://dx.doi.org/10.1159/000326409

Zhai J, Harbour JW, Smith ME, Davila RM. Correlation study of benign cytomorphology and final clinical diagnosis. Acta Cytol 2008; 52: 196-200. http://dx.doi.org/10.1159/000325479

Davis JL, Solomon D, Nussenblatt RB, et al. Immunocytochemical staining of vitreous cells. Indications, techniques, and results. Ophthalmology 1992; 99: 250-56.

Char DJ, Ljung BM, Miller T, et al. Intraocular-CNS lymphoma (ocular reticulum cell sarcoma): Diagnosis and management. Ophthalmology 1988; 95: 625-30.

Weiss LM, Warnke RA, Sklar J, et al. Molecular analysis of the t(14; 18) chromosomal translocation in malignant lymphomas. N Engl J Med 1987; 317: 1185-9. http://dx.doi.org/10.1056/NEJM198711053171904

Char DH, Margolis L, Newman AB. Ocular reticulum cell sarcoma. Am J Ophthalmol 1981; 91: 480-3.

Brown SM, Jampol LM, Cantrill HL. Intraocular-CNS lymphoma presenting as retinal vasculitis. Surv Ophthalmol 1994; 39: 133-40. http://dx.doi.org/10.1016/0039-6257(94)90158-9

Zaldivar RA, Martin DF, Holden JT, et al. Primary intraocular lymphoma: clinical, cytologic and flow cytometric analysis. Ophthalmology 2004; 111: 1762-7.

Rousset F, Garcia E, Defrance T, et al. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 1992; 89: 1890-3. http://dx.doi.org/10.1073/pnas.89.5.1890

Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 235-42. http://dx.doi.org/10.1056/NEJMoa011795

Arcinue CA, Hochberg F, Neumann R, Foster CS. Reevaluation of Diagnostic Criteria for PIOL. Ophtlamol (in press).

Chan CC, Whitcup SM, Solomon D, et al. Interleukin-10 in the vitreous of primary intraocular lymphoma. Am J Ophthalmol 1995; 120: 671-73.

Whitcup SM, Stark-Vancs V, Wittes RE, et al. Association of interleukin-10 in the vitreous and cerebral spinal fluid and primary central nervous system lymphoma. Arch Ophthalmol 1997; 115: 1157-60. http://dx.doi.org/10.1001/archopht.1997.01100160327010

Wolf LA, Reed GF, Buggage RR, et al. Vitreous cytokine levels. Ophthalmology 2003; 110: 1671-72. http://dx.doi.org/10.1016/S0161-6420(03)00811-X

Cassoux N, Giron A, Bodaghi B, et al. IL-10 measurement in aqueous humor for screening patients with suspicion of primary intraocular lymphoma. Invest Ophthalmol Vis Sci 2007; 48: 3253-59. http://dx.doi.org/10.1167/iovs.06-0031

Chan CC, Whitcup SC, Solomon D, et al. Interleukin-10 in the vitreous of patients with primary intraocular lymphoma. Am J Ophthalmol 1995; 120: 671-3.

Akpek EK, Maca S, Christen WG, et al. Elevated vitreal interleukin-10 level is not diagnostic of intraocular-CNS lymphoma. Ophthalmology 1999; 106: 2291-5. http://dx.doi.org/10.1016/S0161-6420(99)90528-6

Katai N, Kuroiwa S, Fujimori K, et al. Diagnosis of intraocular-CNS lymphoma by polymerase chain reaction. Graefes Arch Clin Exp Ophthalmol 1997; 235: 431-6. http://dx.doi.org/10.1007/BF00947062

Shen DF, Zhuang Z, LeHoang P, et al. Utility of microdissection and polymerase chain reaction for the detection of immunoglobulin gene rearrangement and translocation in intraocular-CNS lymphoma. Ophthalmology 1998; 105: 1664-9. http://dx.doi.org/10.1016/S0161-6420(98)99036-4

Chen Y-T, Whitney KD, Chen Y. Clonality analysis of B-cell lymphoma in fresh-frozen and paraffin embedded tissues: The effects of variable polymerase chain reaction parameters. Mod Pathol 1994; 7: 429-34.

Abdel-Rheheim FA, Edwards E, Arber DA. Utility of a rapid polymerase chain reaction panel for the detection of molecular changes in B-cell lymphoma. Arch Pathol Lab Med 1996; 120: 357-63.

Missotten T, Tielemans D, Bromberg JE, van Hagen PM, van Lochem EG, et al. Multicolor flowcytometric immunophenotyping is a valuable tool for detection of intraocular lymphoma. Ophthalmology 2013; 120(5): 991-6. http://dx.doi.org/10.1016/j.ophtha.2012.11.007

Foster CS, Vitale AT. Diagnosis and Treatment of Uveitis. 2nd ed. India: Jaypee Brothers Medical Publishers 2013.




How to Cite

A. Bajwa, & C. Stephen Foster. (2013). Diagnostic Testing of Primary Vitreo-Retinal Lymphoma. Journal of Analytical Oncology, 2(3),  182–187. https://doi.org/10.6000/1927-7229.2013.02.03.9